These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21505158)

  • 1. Letter by Dregelid regarding article, "Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease".
    Dregelid E
    Circ Cardiovasc Interv; 2011 Apr; 4(2):e12; author reply e13. PubMed ID: 21505158
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
    Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
    Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Clinical Outcomes of Autologous Bone Marrow Mononuclear Cell Implantation in Patients With Severe Thromboangiitis Obliterans.
    Mohamad Yusoff F; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Kihara Y; Nakashima A; Higashi Y
    Circ J; 2020 Mar; 84(4):650-655. PubMed ID: 32132348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter by Dregelid regarding article, "Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)".
    Dregelid E
    Circ Cardiovasc Interv; 2011 Jun; 4(3):e18. PubMed ID: 21673319
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of autologous bone marrow mononuclear cell transplantation in treating lower limb thromboangiitis obliterans].
    Wang W; Liu C; Qiao T; Liu C; Huang D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Apr; 24(4):420-3. PubMed ID: 20459002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Repeated Bone Marrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trial.
    Molavi B; Zafarghandi MR; Aminizadeh E; Hosseini SE; Mirzayi H; Arab L; Baharvand H; Aghdami N
    Arch Iran Med; 2016 Jun; 19(6):388-96. PubMed ID: 27293053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.
    Uyanık SA; Öğüşlü U; Aminu IS; Yılmaz B; Çevik H; Atlı E; Gümüş B
    AJR Am J Roentgenol; 2021 Feb; 216(2):421-427. PubMed ID: 33325735
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined revascularization and free-tissue transfer for limb salvage in a Buerger disease patient.
    Ikeda K; Yotsuyanagi T; Arai K; Suda T; Saito T; Ezoe K
    Ann Vasc Surg; 2012 Apr; 26(3):422.e5-8. PubMed ID: 22284776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. Commentary.
    Forbes TL
    J Vasc Surg; 2010 Jun; 51(6):1568. PubMed ID: 20488329
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
    Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
    Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.
    Yusoff FM; Kajikawa M; Matsui S; Hashimoto H; Kishimoto S; Maruhashi T; Chowdhury M; Noma K; Nakashima A; Kihara Y; Sueda T; Higashi Y
    Sci Rep; 2019 May; 9(1):7711. PubMed ID: 31118440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
    Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
    Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of angiogenesis in rat ischemic limb by intramuscular implantation of mononuclear fraction cells from autologous bone marrow.
    Larionov PM; Chernyavskii AM; Novruzov RB; Lushnikova EL; Subbotin DV; Sergeevichev DS; Kuznetsova IV; Karas'kov AM; Nepomnyashchikh LM
    Bull Exp Biol Med; 2011 Feb; 150(4):530-4. PubMed ID: 22268058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.